Guardant Health
GH
$27.10
Share price
-1.35%
Change (1 day)
-13.67%
Change (1 year)
Categories
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.
Guardant Health (GH) - Net assets
Net assets on the balance sheet as of March 2024 : $68.28 M
According to Guardant Health
's latest financial reports the company has $68.28 M in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Guardant Health - Net assets on balance sheet (from 2017 to 2024)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-12-31 | $0.15 B | 163.68% |
| 2022-12-31 | $60.18 M | -90.67% |
| 2021-12-31 | $0.64 B | -52.42% |
| 2020-12-31 | $1.35 B | 59.86% |
| 2019-12-31 | $0.84 B | 61.54% |
| 2018-12-31 | $0.52 B | 70.1% |
| 2017-12-31 | $0.30 B | 287.23% |
| 2016-12-31 | $79.69 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Neogen NEOG | $3.14 B | 4,507.41% | 🇺🇸 USA |
 Natera NTRA | $0.79 B | 1,062.94% | 🇺🇸 USA |